SAB Biotherapeutics, Inc.SABSNASDAQ
Loading
Debt Growth AcceleratingAccelerating
Percentile Rank100
5Y CAGR+33.8%
Studio
Year-over-Year Change

Year-over-year debt growth rate

5Y CAGR
+33.8%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
4.3x
Strong expansion
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
202527.45%
2024-20.96%
2023-0.37%
2022-30.38%
20214.80%
20206.40%
20190.00%